A 12-week treatment with fractional CO<sub>2</sub>laser for vulvovaginal atrophy: a pilot studyStefano Salvatore, Umberto Leone Roberti Maggiore, Rossella E. Nappi et al.|Climacteric|2014Cited by 302
Sexual function after fractional microablative CO<sub>2</sub>laser in women with vulvovaginal atrophyStefano Salvatore, Umberto Leone Roberti Maggiore, Rossella E. Nappi et al.|Climacteric|2014Cited by 212
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE SurveyRossella E. Nappi, Michael Krychman, Santiago Palacios et al.|Climacteric|2015Cited by 211
Evidence-based guideline: premature ovarian insufficiency,Nick Panay, M. Flanagan, Walter A. Rocca et al.|Human Reproduction Open|2024Cited by 117
The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life surveyRossella E. Nappi, Nick Panay, Santiago Palacios et al.|Menopause The Journal of The North American Menopause Society|2018Cited by 115